There might be an improvement in insulin secretion as well as a reduction in systemic insulin resistance.<h4>Conclusion</h4>Treatment of CF patients without diabetes with CFTR modulator therapies can cause recurrent hypoglycaemic episodes which resolve with dietary measures. The gene discussed is CFTR; the disease is cystic fibrosis.